Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Elbit Systems Ltd.

www.elbitsystems.com

Latest From Bayer Consumer Care

Turkey Company Roundup: Top Exec Appointments, R&D Call

Top management changes have taken place at Sandoz Turkey, while Alvimedica, a leading Turkish medical devices company, has a new CEO and the Bayer Consumer Care Business has appointed a new country manager. Meanwhile, Sanofi has launched a platform to support Turkish pharmaceutical researchers through its global network and facilities.

BioPharmaceutical Turkey

Alka-Seltzer ‘Apples-To-Oranges’ Comparison With NyQuil Smells Rotten To NAD

Bayer discontinues ad comparing Alka-Seltzer Plus Night Cold & Flu, which is indicated for nasal decongestion, with P&G's NyQuil Cold & Flu, which is not.

Consumer United States

Alka-Seltzer ‘Apples-To-Oranges’ Comparison With NyQuil Smells Rotten To NAD

Bayer discontinues an ad comparing Alka-Seltzer Plus Night Cold & Flu, which is indicated for nasal decongestion, with P&G's NyQuil Cold & Flu, which is not. The review centered on NAD's “apples to oranges” principle that marketers should not mislead on the similarities of competing formulas.

Consumer United States

Deals Shaping The Medical Industry, June 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced April through May 2014.

BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Diversified
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Elbit Systems Ltd.
  • Senior Management
  • Joseph Ackerman, Pres. & CEO
  • Contact Info
  • Elbit Systems Ltd.
    Phone: (972) 4 8315315
    P.O. Box 539
    Haifa, 31053
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register